Found: 65
Select item for more details and to access through your institution.
Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long‐term follow up of a phase III study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 7, p. 749, doi. 10.1002/ajh.25795
- By:
- Publication type:
- Article
Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 1, p. 37, doi. 10.1002/ajh.24572
- By:
- Publication type:
- Article
The prognostic value of positron emission tomography performed after two courses ( INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL).
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 6, p. 499, doi. 10.1002/ajh.23994
- By:
- Publication type:
- Article
SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 3, p. 185, doi. 10.1002/ajh.23372
- By:
- Publication type:
- Article
Baseline Total Metabolic Tumor Volume is Prognostic for Refractoriness to Immunochemotherapy in DLBCL: Results From GOYA.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e804, doi. 10.1016/j.clml.2022.04.010
- By:
- Publication type:
- Article
ABCL-021: FRONT-MIND: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Comparing Efficacy and Safety of Tafasitamab + Lenalidomide + R-CHOP vs R-CHOP Alone for Newly-Diagnosed High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma (DLBCL)
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S376, doi. 10.1016/S2152-2650(21)01860-7
- By:
- Publication type:
- Article
Poster: ABCL-021: FRONT-MIND: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Comparing Efficacy and Safety of Tafasitamab + Lenalidomide + R-CHOP vs R-CHOP Alone for Newly-Diagnosed High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma (DLBCL)
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01533-0
- By:
- Publication type:
- Article
BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor Prognosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Potential Benefit of Involved-Field Radiotherapy for Patients With Relapsed-Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
An International Multicenter Project on Secondary Myelofibrosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S91, doi. 10.1016/j.clml.2016.07.127
- By:
- Publication type:
- Article
Role of Chemotherapy and Allografting in the Treatment of Acute Lymphoblastic Leukemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Safety and efficacy of single-agent bendamustine after failure of brentuximab vedotin in patients with relapsed or refractory hodgkin's lymphoma: experience with 27 patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Brentuximab Vedotin in CD30-Positive Lymphomas: A SIE, SIES, and GITMO Position Paper.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Fludarabine, Cyclophosphamide, and Rituximab in Salvage Therapy of Waldenström's Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 2, p. 231, doi. 10.1016/j.clml.2013.02.011
- By:
- Publication type:
- Article
Update in indolent non-Hodgkin lymphoma (NHL): paradigm for Waldenström's macroglobulinemia (WM)
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Update in Indolent Non-Hodgkin Lymphoma (NHL): Paradigm for Waldenström's Macroglobulinemia (WM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 149, doi. 10.3816/CLML.2011.n.035
- By:
- Publication type:
- Article
Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 16, p. 3954, doi. 10.1002/cncr.26708
- By:
- Publication type:
- Article
The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 9, p. 1884, doi. 10.1002/cncr.25743
- By:
- Publication type:
- Article
Oxaliplatin-Based Chemotherapy (Dexamethasone, High-Dose Cytarabine, and Oxaliplatin) ± Rituximab Is an Effective Salvage Regimen in Patients With Relapsed or Refractory Lymphoma.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 19, p. 4573, doi. 10.1002/cncr.25216
- By:
- Publication type:
- Article
Consensus conference on the use of 90-yttrium-ibritumomab tiuxetan therapy in clinical practice. A project of the Italian Society of Hematology.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 2, p. 147, doi. 10.1002/ajh.21602
- By:
- Publication type:
- Article
Follicular Lymphoma: The Management of Elderly Patient.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2017, v. 9, n. 1, p. 1, doi. 10.4084/MJHID.2017.009
- By:
- Publication type:
- Article
Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy.
- Published in:
- Intensive Care Medicine, 2010, v. 36, n. 10, p. 1666, doi. 10.1007/s00134-010-1934-1
- By:
- Publication type:
- Article
A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T‐cell lymphomas, unspecified, and 496 diffuse large B‐cell lymphomas: Experience of the Intergruppo Italiano LinfomiInstitutions participating in the Intergruppo Italiano Linfomi study of peripheral T‐cell lymphoma include the following (principal investigators are listed in parentheses): Struttura Complessa di Ematologia, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy (A. Gallamini, D. Mattei, and R. Calvi); Struttura Complessa di Ematologia, Azienda Ospedaliera San Giovanni Battista, Turin, Italy (E. Gallo and U. Vitolo); Cattedra di Ematologia, Università degli Studi di Torino, Turin, Italy (M. Boccadoro, C. Tarella, and M. Ladetto); Divisione di Onco‐Ematologia, Istituto di Ricovero a Carattere Scientifico Candiolo, Turin, Italy (M. Aglietta and D. Rota Scalabrini); Struttura Complessa di Medicina, Ospedale di Biella, Biella, Italy (S. Fontana and A. Tonso); Struttura Complessa di M
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 7, p. 1601, doi. 10.1002/cncr.20531
- By:
- Publication type:
- Article
High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 11, p. 2748
- By:
- Publication type:
- Article
XVI. CNS prophylaxis in aggressive lymphomas: for whom and how.
- Published in:
- Hematological Oncology, 2013, v. 31, p. 89, doi. 10.1002/hon.2074
- By:
- Publication type:
- Article
G-CSF use in patients receiving first-line chemotherapy for non-Hodgkin's lymphoma (NHL) and granulocyte-colony stimulating factors (G-CSF) as observed in clinical practice in Italy.
- Published in:
- Medical Oncology, 2016, v. 33, n. 12, p. 1, doi. 10.1007/s12032-016-0850-9
- By:
- Publication type:
- Article
A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00900-7
- By:
- Publication type:
- Article
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B‐cell lymphoma patients treated in the FIL‐DLCL04 trial.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 5, p. 1184, doi. 10.1111/bjh.17971
- By:
- Publication type:
- Article
Partial responses to ibrutinib in Waldenström macroglobulinaemia ‐ good enough?
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 423, doi. 10.1111/bjh.17228
- By:
- Publication type:
- Article
Genomic alterations of ribosomal protein genes in diffuse large B cell lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 2, p. 330, doi. 10.1111/bjh.15442
- By:
- Publication type:
- Article
A retrospective study of R‐DHAP/Ox for early progressing follicular lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 5, p. 828, doi. 10.1111/bjh.15057
- By:
- Publication type:
- Article
Diffuse large B cell lymphoma cell of origin by digital expression profiling in the REAL07 Phase 1–2 study.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 453, doi. 10.1111/bjh.14817
- By:
- Publication type:
- Article
Safety and efficacy of ruxolitinib in myelofibrosis patients without splenomegaly.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 1, p. 160, doi. 10.1111/bjh.13758
- By:
- Publication type:
- Article
Reduced intensity VEPEMB regimen compared with standard ABVD in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi ( FIL).
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 6, p. 879, doi. 10.1111/bjh.13904
- By:
- Publication type:
- Article
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 1, p. 111, doi. 10.1111/bjh.13803
- By:
- Publication type:
- Article
Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 69, doi. 10.1111/bjh.12845
- By:
- Publication type:
- Article
Safety and efficacy of <sup>90</sup> Yttrium- Ibritumomab- Tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 5, p. 710, doi. 10.1111/bjh.12695
- By:
- Publication type:
- Article
RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2012, v. 156, n. 2, p. 234, doi. 10.1111/j.1365-2141.2011.08947.x
- By:
- Publication type:
- Article
Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Hypermethylation of the DNA Repair Gene O[sup 6]-Methylguanine DNA Methyltransferase and Survival of Patients With Diffuse Large B-Cell Lymphoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2002, v. 94, n. 1, p. 26, doi. 10.1093/jnci/94.1.26
- By:
- Publication type:
- Article
Correction to: The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of pet-guided treatments.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Positron emission tomography in the staging of patients with Hodgkin's lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Molecular heterogeneity of B-lineage diffuse large cell lymphoma.
- Published in:
- Genes, Chromosomes & Cancer, 1996, v. 16, n. 1, p. 21, doi. 10.1002/(SICI)1098-2264(199605)16:1<21::AID-GCC3>3.0.CO;2-5
- By:
- Publication type:
- Article
A comparison of the prognostic performance of the Lugano 2014 and RECIL 2017 response criteria in patients with NHL from the phase III GOYA and GALLIUM trials.
- Published in:
- EJHaem, 2023, v. 4, n. 4, p. 1042, doi. 10.1002/jha2.796
- By:
- Publication type:
- Article
A prognostic model integrating PET‐derived metrics and image texture analyses with clinical risk factors from GOYA.
- Published in:
- EJHaem, 2022, v. 3, n. 2, p. 406, doi. 10.1002/jha2.421
- By:
- Publication type:
- Article
Impact of immunochemotherapy with R‐bendamustine or R‐CHOP for treatment naïve advanced‐stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 655, doi. 10.1002/hon.3184
- By:
- Publication type:
- Article
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 293, doi. 10.1002/hon.2864
- By:
- Publication type:
- Article